Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Mark Gurney; Anmol Baranwal; Allison Rosenthal; Mohamed A. Kharfan-Dabaja; Saad S. Kenderian; Yi Lin; Mithun Vinod Shah

doi:10.1001/jamaoncol.2023.7182

Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Mark Gurney, Anmol Baranwal, Allison Rosenthal, Mohamed A. Kharfan-Dabaja, Saad S. Kenderian, Yi Lin, Mithun Vinod Shah

Hematology

Research output: Contribution to journal › Article › peer-review

Abstract

This case-control study examines the incidence and risks of myeloid neoplasms in adults treated for B-cell lymphoproliferative disorders or multiple myeloma.

Original language	English (US)
Journal	JAMA Oncology
DOIs	https://doi.org/10.1001/jamaoncol.2023.7182
State	Accepted/In press - 2024

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2023.7182

Cite this

@article{a74f6287ce7041279d04fe806d92b204,

title = "Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy",

abstract = "This case-control study examines the incidence and risks of myeloid neoplasms in adults treated for B-cell lymphoproliferative disorders or multiple myeloma.",

author = "Mark Gurney and Anmol Baranwal and Allison Rosenthal and Kharfan-Dabaja, {Mohamed A.} and Kenderian, {Saad S.} and Yi Lin and Shah, {Mithun Vinod}",

year = "2024",

doi = "10.1001/jamaoncol.2023.7182",

language = "English (US)",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

AU - Gurney, Mark

AU - Baranwal, Anmol

AU - Rosenthal, Allison

AU - Kharfan-Dabaja, Mohamed A.

AU - Kenderian, Saad S.

AU - Lin, Yi

AU - Shah, Mithun Vinod

PY - 2024

Y1 - 2024

N2 - This case-control study examines the incidence and risks of myeloid neoplasms in adults treated for B-cell lymphoproliferative disorders or multiple myeloma.

AB - This case-control study examines the incidence and risks of myeloid neoplasms in adults treated for B-cell lymphoproliferative disorders or multiple myeloma.

UR - http://www.scopus.com/inward/record.url?scp=85186102640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186102640&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2023.7182

DO - 10.1001/jamaoncol.2023.7182

M3 - Article

C2 - 38386311

AN - SCOPUS:85186102640

SN - 2374-2437

JO - JAMA Oncology

JF - JAMA Oncology

ER -

Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this